Follow
chun chou
chun chou
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity
K Xu, N Yin, M Peng, EG Stamatiades, A Shyu, P Li, X Zhang, MH Do, ...
Science 371 (6527), 405-410, 2021
2052021
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation
CC Lin, TR Bradstreet, EA Schwarzkopf, J Sim, JA Carrero, C Chou, ...
Nature communications 5 (1), 3551, 2014
1822014
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells
S Li, M Liu, MH Do, C Chou, EG Stamatiades, BG Nixon, W Shi, X Zhang, ...
Nature 587 (7832), 121-125, 2020
1722020
TGF-β suppresses type 2 immunity to cancer
M Liu, F Kuo, KJ Capistrano, D Kang, BG Nixon, W Shi, C Chou, MH Do, ...
Nature 587 (7832), 115-120, 2020
1512020
c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells
C Chou, AK Pinto, JD Curtis, SP Persaud, M Cella, CC Lin, BT Edelson, ...
Nature immunology 15 (9), 884-893, 2014
1082014
The transcription factor AP4 mediates resolution of chronic viral infection through amplification of germinal center B cell responses
C Chou, DJ Verbaro, E Tonc, M Holmgren, M Cella, M Colonna, ...
Immunity 45 (3), 570-582, 2016
982016
IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
CC Lin, TR Bradstreet, EA Schwarzkopf, NN Jarjour, C Chou, ...
Journal of Experimental Medicine 213 (2), 251-271, 2016
882016
Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses
K Xu, N Yin, M Peng, EG Stamatiades, S Chhangawala, A Shyu, P Li, ...
Immunity 54 (5), 976-987. e7, 2021
602021
Cytotoxic granzyme C–expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity
BG Nixon, C Chou, C Krishna, S Dadi, AO Michel, AE Cornish, ...
Science immunology 7 (70), eabi8642, 2022
542022
Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder
AT Satpathy, CG Briseño, X Cai, DG Michael, C Chou, S Hsiung, ...
Blood, The Journal of the American Society of Hematology 123 (19), 2968-2977, 2014
542014
Tissue-resident lymphocytes across innate and adaptive lineages
C Chou, MO Li
Frontiers in Immunology 9, 399246, 2018
522018
Programme of self-reactive innate-like T cell-mediated cancer immunity
C Chou, X Zhang, C Krishna, BG Nixon, S Dadi, KJ Capistrano, ...
Nature 605 (7908), 139-145, 2022
412022
BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen
Y Xia, K Sandor, JA Pai, B Daniel, S Raju, R Wu, S Hsiung, Y Qi, ...
Immunity 55 (7), 1200-1215. e6, 2022
332022
Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance
MH Do, X Wang, X Zhang, C Chou, BG Nixon, KJ Capistrano, M Peng, ...
Journal of Experimental Medicine 217 (1), 2020
312020
Pathogenic mechanisms of hypertrophic cardiomyopathy beyond sarcomere dysfunction
C Chou, MT Chin
International journal of molecular sciences 22 (16), 8933, 2021
302021
A silencer-proximal intronic region is required for sustained CD4 expression in postselection thymocytes
DM Henson, C Chou, N Sakurai, T Egawa
The Journal of Immunology 192 (10), 4620-4627, 2014
302014
Reprogramming tumour-associated macrophages to outcompete cancer cells
X Zhang, S Li, I Malik, MH Do, L Ji, C Chou, W Shi, KJ Capistrano, ...
Nature 619 (7970), 616-623, 2023
262023
Re (de) fining innate lymphocyte lineages in the face of cancer
C Chou, MO Li
Cancer immunology research 6 (4), 372-377, 2018
92018
Myc or no Myc, that is the question
C Chou, T Egawa
The EMBO Journal 34 (15), 1990-1991, 2015
92015
Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis
MH Do, W Shi, L Ji, E Ladewig, X Zhang, RM Srivastava, KJ Capistrano, ...
Immunity 56 (11), 2555-2569. e5, 2023
42023
The system can't perform the operation now. Try again later.
Articles 1–20